Abstract Background and aims The European Atherosclerosis Society (EAS) Lipid Clinics
Network promoted a survey in order to identify and understand how and when lipoprotein …

Lipoprotein (a)(Lp (a)) is a complex circulating lipoprotein, and increasing evidence has
demonstrated its role as a risk factor for atherosclerotic cardiovascular disease (ASCVD) …

Abstract Purpose of Review The purpose of this article is to review current evidence for
lipoprotein (a)(Lp (a)) as a risk factor for multiple cardiovascular (CV) disease phenotypes …

Abstract Lipoprotein (a)[Lp (a)] is a well-recognized, independent risk factor for
atherosclerotic cardiovascular disease, with elevated levels estimated to be prevalent in …

Lipoprotein (a)[Lp (a)] is a well-recognized, independent risk factor for atherosclerotic
cardiovascular disease, with elevated levels estimated to be prevalent in 20% of the …

Aims To investigate plasma lipoprotein (a)[Lp (a)] levels measured in routine clinical care
and their association with mortality and cardiovascular disease. Methods and results This …

It has been estimated that∼ 37% of the US population judged to be at high risk for
developing coronary artery disease (CAD), based on the National Cholesterol Education …

Background: High plasma concentrations of lipoprotein (a)[Lp (a)] are associated with an
increased cardiovascular risk. Current guidelines recommend measurement of only a single …

Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and
mortality worldwide, although optimal medical therapy has been prescribed for primary and …

Evidence from Mendelian randomization studies suggest that lipoprotein (a)(Lp (a)) has a
causal role in the development of atherosclerotic cardiovascular disease risk. However …